Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-controlled Trial of D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia

NCT00963924 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00963924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00963924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-controlled Trial of D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2009
Completion date
June 30, 2011
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia